Key Points
-
Complex regional pain syndrome (CRPS) is a persistent pain condition that often results from an injury and usually affects a single limb.
-
An unusually high level of pain during the week after the injury seems to be the most robust risk factor for CRPS development.
-
Post-traumatic inflammation has been identified as a major component of acute CRPS, and growth factors, catecholamines and autoantibodies have also been implicated in CRPS pathogenesis.
-
A growing body of evidence indicates that disturbances of body representation and body perception are key features of the CRPS phenotype.
-
Small non-coding RNAs (microRNAs) are emerging as diagnostic and prognostic biomarkers for CRPS.
-
A single marker for CRPS is unlikely to be found; however, a range of biomarkers might assist in clinical diagnosis and guide prognosis and treatment.
Abstract
Complex regional pain syndrome (CRPS) is a pain condition that usually affects a single limb, often following an injury. The underlying pathophysiology seems to be complex and probably varies between patients. Clinical diagnosis is based on internationally agreed-upon criteria, which consider the reported symptoms, presence of signs and exclusion of alternative causes. Research into CRPS biomarkers to support patient stratification and improve diagnostic certainty is an important scientific focus, and recent progress in this area provides an opportunity for an up-to-date topical review of measurable disease-predictive, diagnostic and prognostic parameters. Clinical and biochemical attributes of CRPS that may aid diagnosis and determination of appropriate treatment are delineated. Findings that predict the development of CRPS and support the diagnosis include trauma-related factors, neurocognitive peculiarities, psychological markers, and local and systemic changes that indicate activation of the immune system. Analysis of signatures of non-coding microRNAs that could predict the treatment response represents a new line of research. Results from the past 5 years of CRPS research indicate that a single marker for CRPS will probably never be found; however, a range of biomarkers might assist in clinical diagnosis and guide prognosis and treatment.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Marinus, J. et al. Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol. 10, 637–648 (2011).
Birklein, F., O'Neill, D. & Schlereth, T. Complex regional pain syndrome: an optimistic perspective. Neurology 84, 89–96 (2015).
Parkitny, L. et al. Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurology 80, 106–117 (2013).
Harden, R. N. et al. Validation of proposed diagnostic criteria (the “Budapest Criteria”) for Complex Regional Pain Syndrome. Pain 150, 268–274 (2010).
Beerthuizen, A. et al. Demographic and medical parameters in the development of complex regional pain syndrome type 1 (CRPS1): prospective study on 596 patients with a fracture. Pain 153, 1187–1192 (2012).
Bruehl, S. et al. Complex regional pain syndrome: evidence for warm and cold subtypes in a large prospective clinical sample. Pain 157, 1674–1681 (2016).
Mugge, W., Schouten, A. C., van Hilten, J. J. & van der Helm, F. C. Impaired inhibitory force feedback in fixed dystonia. IEEE Trans. Neural Syst. Rehabil. Eng. 24, 475–484 (2016).
Shi, X. et al. Facilitated spinal neuropeptide signaling and upregulated inflammatory mediator expression contribute to postfracture nociceptive sensitization. Pain 156, 1852–1863 (2015).
Birklein, F. & Schlereth, T. Complex regional pain syndrome — significant progress in understanding. Pain 156 (Suppl. 1), S94–S103 (2015).
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89–95 (2001).
Roh, Y. H. et al. Factors associated with complex regional pain syndrome type I in patients with surgically treated distal radius fracture. Arch. Orthop. Trauma Surg. 134, 1775–1781 (2014).
Sumitani, M. et al. Perioperative factors affecting the occurrence of acute complex regional pain syndrome following limb bone fracture surgery: data from the Japanese Diagnosis Procedure Combination database. Rheumatology 53, 1186–1193 (2014).
Moseley, G. L. et al. Intense pain soon after wrist fracture strongly predicts who will develop complex regional pain syndrome: prospective cohort study. J. Pain 15, 16–23 (2014).
Jellad, A., Salah, S. & Ben Salah Frih, Z. Complex regional pain syndrome type I: incidence and risk factors in patients with fracture of the distal radius. Arch. Phys. Med. Rehabil. 95, 487–492 (2014).
Pfau, D. B. et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): reference data for the trunk and application in patients with chronic postherpetic neuralgia. Pain 155, 1002–1015 (2014).
Beerekamp, M. S. et al. Epidemiology of extremity fractures in the Netherlands. Injury 48, 1355–1362 (2017).
Somersalo, A. et al. Incidence of fractures requiring inpatient care. Acta Orthop. 85, 525–530 (2014).
Margalit, D., Ben Har, L., Brill, S. & Vatine, J. J. Complex regional pain syndrome, alexithymia, and psychological distress. J. Psychosom. Res. 77, 273–277 (2014).
Bean, D. J., Johnson, M. H. & Kydd, R. R. Relationships between psychological factors, pain, and disability in complex regional pain syndrome and low back pain. Clin. J. Pain 30, 647–653 (2014).
Speck, V., Schlereth, T., Birklein, F. & Maihofner, C. Increased prevalence of posttraumatic stress disorder in CRPS. Eur. J. Pain 21, 466–473 (2017).
Barad, M. J., Ueno, T., Younger, J., Chatterjee, N. & Mackey, S. Complex regional pain syndrome is associated with structural abnormalities in pain-related regions of the human brain. J. Pain 15, 197–203 (2014).
Erpelding, N. et al. Habenula functional resting-state connectivity in pediatric CRPS. J. Neurophysiol. 111, 239–247 (2014).
Baliki, M. N., Mansour, A. R., Baria, A. T. & Apkarian, A. V. Functional reorganization of the default mode network across chronic pain conditions. PLoS ONE 9, e106133 (2014).
Di Pietro, F., Stanton, T. R., Moseley, G. L., Lotze, M. & McAuley, J. H. Interhemispheric somatosensory differences in chronic pain reflect abnormality of the healthy side. Hum. Brain Mapp. 36, 508–518 (2015).
Upadhyay, J., Geber, C., Hargreaves, R., Birklein, F. & Borsook, D. A critical evaluation of validity and utility of translational imaging in pain and analgesia: utilizing functional imaging to enhance the process. Neurosci. Biobehav. Rev. 84, 407–423 (2017).
Di Pietro, F. et al. Primary somatosensory cortex function in complex regional pain syndrome: a systematic review and meta-analysis. J. Pain 14, 1001–1018 (2013).
Torta, D. M., Legrain, V., Rossetti, Y. & Mouraux, A. Prisms for pain. Can visuo-motor rehabilitation strategies alleviate chronic pain? Eur. J. Pain 20, 64–69 (2016).
Moseley, G. L., Gallace, A., Di Pietro, F., Spence, C. & Iannetti, G. D. Limb-specific autonomic dysfunction in complex regional pain syndrome modulated by wearing prism glasses. Pain 154, 2463–2468 (2013).
Cohen, H. et al. Clinical evidence of parietal cortex dysfunction and correlation with extent of allodynia in CRPS type 1. Eur. J. Pain 17, 527–538 (2013).
Hall, J. et al. Sensorimotor dysfunction after limb fracture — an exploratory study. Eur. J. Pain 20, 1402–1412 (2016).
Reinersmann, A. et al. Impaired spatial body representation in complex regional pain syndrome type 1 (CRPS I). Pain 153, 2174–2181 (2012).
Michal, M. et al. Association of neglect-like symptoms with anxiety, somatization, and depersonalization in complex regional pain syndrome. Pain Med. 18, 764–772 (2017).
Hall, J. et al. Pain and other symptoms of CRPS can be increased by ambiguous visual stimuli — an exploratory study. Eur. J. Pain 15, 17–22 (2011).
Gierthmuhlen, J. et al. Sensory signs in complex regional pain syndrome and peripheral nerve injury. Pain 153, 765–774 (2012).
Mainka, T. et al. Comparison of muscle and joint pressure-pain thresholds in patients with complex regional pain syndrome and upper limb pain of other origin. Pain 155, 591–597 (2014).
Lenz, M. et al. Bilateral somatosensory cortex disinhibition in complex regional pain syndrome type I. Neurology 77, 1096–1101 (2011).
Catley, M. J., O'Connell, N. E., Berryman, C., Ayhan, F. F. & Moseley, G. L. Is tactile acuity altered in people with chronic pain? A systematic review and meta-analysis. J. Pain 15, 985–1000 (2014).
Guo, T. Z. et al. Immobilization contributes to exaggerated neuropeptide signaling, inflammatory changes, and nociceptive sensitization after fracture in rats. J. Pain 15, 1033–1045 (2014).
Lenz, M. et al. Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months. Pain 154, 2142–2149 (2013).
Kramer, H. H. et al. TNF-α in CRPS and 'normal' trauma — significant differences between tissue and serum. Pain 152, 285–290 (2011).
Kramer, H. H. et al. Osteoprotegerin: a new biomarker for impaired bone metabolism in complex regional pain syndrome? Pain 155, 889–895 (2014).
Kohr, D. et al. Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome. Pain 152, 2690–2700 (2011).
Dubuis, E. et al. Longstanding complex regional pain syndrome is associated with activating autoantibodies against alpha-1a adrenoceptors. Pain 155, 2408–2417 (2014).
Hendrickson, J. E. et al. Complex regional pain syndrome and dysautonomia in a 14-year-old girl responsive to therapeutic plasma exchange. J. Clin. Apher. 31, 368–374 (2016).
Goebel, A. et al. The passive transfer of immunoglobulin G serum antibodies from patients with longstanding complex regional pain syndrome. Eur. J. Pain 15, 504.e1–504.e6 (2011).
Tekus, V. et al. A CRPS-IgG-transfer-trauma model reproducing inflammatory and positive sensory signs associated with complex regional pain syndrome. Pain 155, 299–308 (2014).
Reilly, J. M. et al. Effects of serum immunoglobulins from patients with complex regional pain syndrome (CRPS) on depolarisation-induced calcium transients in isolated dorsal root ganglion (DRG) neurons. Exp. Neurol. 277, 96–102 (2016).
Alexander, G. M. et al. Plasma amino acids changes in complex regional pain syndrome. Pain Res. Treat. 2013, 742407 (2013).
Baykal, T., Seferoglu, B., Karsan, O., Kiziltunc, A. & Senel, K. Antioxidant profile in patients with complex regional pain syndrome type I. Int. J. Rheum. Dis. 17, 156–158 (2014).
Ritz, B. W. et al. Elevated blood levels of inflammatory monocytes (CD14+CD16+) in patients with complex regional pain syndrome. Clin. Exp. Immunol. 164, 108–117 (2011).
Guo, T. Z., Wei, T., Li, W. W., Li, X. Q., Clark, J. D. & Kingery, W. S. Immobilization contributes to exaggerated neuropeptide signaling, inflammatory changes, and nociceptive sensitization after fracture in rats. J. Pain 15, 1033–1045 (2014).
Birklein, F. et al. Activation of cutaneous immune responses in complex regional pain syndrome. J. Pain 15, 485–495 (2014).
Osborne, S. et al. Cutaneous immunopathology of long-standing complex regional pain syndrome. Eur. J. Pain 19, 1516–1526 (2015).
Agarwal, V., Bell, G. W., Nam, J. W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. eLife 4, e05005 (2015).
Chen, X., Liang, H., Zhang, J., Zen, K. & Zhang, C. Y. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol. 22, 125–132 (2012).
El Andaloussi, S., Lakhal, S., Mäger, I. & Wood, M. J. Exosomes for targeted siRNA delivery across biological barriers. Adv. Drug Deliv. Rev. 65, 391–397 (2013).
Kowal, J., Tkach, M. & Thery, C. Biogenesis and secretion of exosomes. Curr. Opin. Cell Biol. 29, 116–125 (2014).
Orlova, I. A. et al. MicroRNA modulation in complex regional pain syndrome. J. Transl Med. 9, 195 (2011).
McDonald, M. K. et al. Functional significance of macrophage-derived exosomes in inflammation and pain. Pain 155, 1527–1539 (2014).
Mendell, J. T. & Olson, E. N. MicroRNAs in stress signaling and human disease. Cell 148, 1172–1187 (2012).
McDonald, M. K. et al. Regulation of proinflammatory genes by the circulating microRNA hsa-miR-939. Sci. Rep. 6, 30976 (2016).
Jin, E. H. et al. Genome-wide expression profiling of complex regional pain syndrome. PLoS ONE 8, e79435 (2013).
Janicki, P. K., Alexander, G. M., Eckert, J., Postula, M. & Schwartzman, R. J. Analysis of common single nucleotide polymorphisms in complex regional pain syndrome: genome wide association study approach and pooled DNA strategy. Pain Med. 17, 2344–2352 (2016).
Bean, D. J., Johnson, M. H. & Kydd, R. R. The outcome of complex regional pain syndrome type 1: a systematic review. J. Pain 15, 677–690 (2014).
Bean, D. J., Johnson, M. H., Heiss-Dunlop, W. & Kydd, R. R. Extent of recovery in the first 12 months of complex regional pain syndrome type-1: a prospective study. Eur. J. Pain 20, 884–894 (2016).
Bean, D. J., Johnson, M. H., Heiss-Dunlop, W., Lee, A. C. & Kydd, R. R. Do psychological factors influence recovery from complex regional pain syndrome type 1? A prospective study. Pain 156, 2310–2318 (2015).
Barnhoorn, K. J. et al. Are pain-related fears mediators for reducing disability and pain in patients with complex regional pain syndrome type 1? An explorative analysis on pain exposure physical therapy. PLoS ONE 10, e0123008 (2014).
van Eijs, F. et al. Predictors of pain relieving response to sympathetic blockade in complex regional pain syndrome type 1. Anesthesiology 116, 113–121 (2012).
Douglas, S. R. et al. Analgesic response to intravenous ketamine is linked to a circulating microRNA signature in female patients with complex regional pain syndrome. J. Pain 16, 814–824 (2015).
Shenoda, B. B., Alexander, G. M. & Ajit, S. K. Hsa-miR-34a mediated repression of corticotrophin releasing hormone receptor 1 regulates pro-opiomelanocortin expression in patients with complex regional pain syndrome. J. Transl Med. 14, 64 (2016).
den Hollander, M. et al. Expose or protect? A randomized controlled trial of exposure in vivo versus pain-contingent treatment as usual in patients with complex regional pain syndrome type 1. Pain 157, 2318–2329 (2016).
Acknowledgements
F.B. acknowledges support from the Deutsche Forschungsgemeinschaft (Germany; grant Bi579/8-1) and the Dietmar-Hopp Foundation. F.B. and C.S. acknowledge support from the European Commission (ncRNAPain, FP7 grant 602133). A.G. has received funding from the Pain Relief Foundation, Liverpool, UK. S.K.A. has received grants from the NIH (National Institute of Neurological Disorders and Stroke 1R21NS082991-01), the Rita Allen Foundation and the Drexel University Clinical and Translational Research Institute.
Author information
Authors and Affiliations
Contributions
All authors contributed equally to researching data for the article, discussions of the content, writing the article, and review and editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Further information
Rights and permissions
About this article
Cite this article
Birklein, F., Ajit, S., Goebel, A. et al. Complex regional pain syndrome — phenotypic characteristics and potential biomarkers. Nat Rev Neurol 14, 272–284 (2018). https://doi.org/10.1038/nrneurol.2018.20
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2018.20
This article is cited by
-
Transient immune activation without loss of intraepidermal innervation and associated Schwann cells in patients with complex regional pain syndrome
Journal of Neuroinflammation (2024)
-
Pain mechanisms in complex regional pain syndrome: a systematic review and meta-analysis of quantitative sensory testing outcomes
Journal of Orthopaedic Surgery and Research (2023)
-
Intermittent versus continuous esketamine infusions for long-term pain modulation in complex regional pain syndrome: protocol of a randomized controlled non-inferiority study (KetCRPS-2)
BMC Musculoskeletal Disorders (2023)
-
Complex Regional Pain Syndrome: Evidence-Based Advances in Concepts and Treatments
Current Pain and Headache Reports (2023)
-
Prediction of the Efficacy of Lumbar Sympathetic Block in Patients with Lower Extremity Complex Regional Pain Syndrome Type 1 Based on the Sympathetic Skin Response
Pain and Therapy (2023)